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Abstract 
Influenza viruses are important pathogens that cause respiratory infections in humans and 
animals.  In addition to vaccination, antiviral drugs against influenza virus play a significant role 
in controlling viral infections by reducing disease progression and virus transmission. Plant 
derived polyphenols are associated with antioxidant activity, anti-carcinogenic, and cardio- and 
neuro-protective actions.  Some polyphenols, such as resveratrol and epigallocatechin gallate 
(EGCG), showed significant anti-influenza activity in vitro and/or in vivo.  Recently we showed 
that quercetin and isoquercetin (quercetin-3-β-D-glucoside), a glucoside form of quercetin, 
significantly reduced the replication of influenza viruses in vitro and in vivo (isoquercetin). The 
antiviral effects of isoquercetin were greater than that of quercetin with lower IC50 values and 
higher in vitro therapeutic index. Thus, we investigated the synthesis and antiviral activities of 
various quercetin derivatives with substitution of C3, C3’, and C5 hydroxyl functions with 
various phenolic ester, alkoxy, and aminoalkoxy moieties. Among newly synthesized 
compounds, quercetin-3-gallate which is structurally related to EGCG showed comparable 
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antiviral activity against influenza virus (porcine H1N1 strain) to that of EGCG with improved in 
vitro therapeutic index.  
 
Key words:  antiviral activity, influenza virus, porcine H1N1 strain, quercetin-3-gallate, 
substituted quercetins. 
 
Influenza infections are responsible for over 3 million cases of illness and up to a half of 
million deaths per year.
1
  Although antiviral drugs against influenza infections are available, the 
emergence of viral resistance to existing antiviral drugs emphasizes the demand for development 
of new antiviral drugs against influenza infections. In the past few years, polyphenols including 
quercetin (1) and its analogs,
2-4
 quercetin-3--galactoside,5 quercetin 3-rhamnoside,6 quercetin 3-
-D-glucoside or isoquercetin (2)7 (Figure 1) were reported effective against influenza 
infections.  Among them, isoquercetin (2) demonstrated a lower IC50 value against influenza 
viruses and higher therapeutic index compared to that of quercetin.
7
 (-)-Epigallocatechin-3-
gallate (EGCG; 3) is the major polyphenol in green tea and reported to have anti-influenza virus 
activity
8,9
 and organic anion-transporting enhancing property.
10
  Quercetin-3-gallate (4) has been 
reported to be effective for the treatment of inflammatory bowel disease by inhibiting Na
+
-K
+
-
ATPase and/or Na
+
/H
+
 exchange activities.
11
 However, the synthesis and anti-influenza virus 
activities of 4 and its hydroxyl aryl analogs have not been reported.  A hybrid of quercetin and 
gallate or its analogs may show improved antiviral activities.  Therefore antiviral activities of 
derivatives of quercetin with various substitutions at the hydroxyl functions were investigated.  
Herein, we report the synthesis and anti-influenza virus activities of compounds 4 - 10 
containing C3-dihydroxybenzoate, C3-aminohydroxybenzoates, C3’-gallate, C3’-
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aminopropyloxy, and C5-propyloxy functions.  Among the derivatives, quercetin-3-gallate (4) 
which is structurally related to EGCG showed comparable antiviral activity against influenza 
virus porcine H1N1 as that of EGCG with improved in vitro therapeutic index.  
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Figure 1.  Quercetin, Isoquercetin, EGCG, quercetin-3-gallate and synthesized quercetin analogs
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 For the synthesis of C3-O-ester analogs of quercetin, a reported selective protection of 
the three most reactive hydroxyl functions at C7, C3’, and C4’ was adapted.12  Hence, 3’,4’,7-tri-
O-benzylquercetin (11), derived from tribenzylation of rutin with potassium carbonate and 
benzyl bromide in DMF followed by removal of the C3-rutinose with hydrochloric acid and 
ethanol, was condensed with 3,4,5-tribenzylgallic acid (12),
13
 N-ethyl-N’-(3-
dimethylaminopropyl)carbodiimide (EDC), and a catalytic amount of 4-dimethylaminopyridine 
4 
 
(DMAP) in dichloromethane to give ester 16 in 64% yield (Scheme 1).  Removal of the benzyl 
ether protecting groups of 16 with hydrogen (15 psi) and 5% palladium over carbon afforded 
quercetin gallate 4 (68% yield).  It should be noted that C5-hydroxyl function is less reactive 
than C3-hydroxyl due to intramolecular hydrogen bonding and resonance conjugation with C4-
keto function. 
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Scheme 1.  Synthesis of quercetin 3-O-analogs 4 - 7
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Similarly, condensation of compound 11 with 2,5-dibenzyloxybenzoic acid (13),
14,15
 4-
benzyloxy-3-(N,N-dibenzylamino)benzoic acid (14), and 3-benzyloxy-4-(N,N-
dibenzylamino)benzoic acid (15) separately gave benzyl esters 17, 18, and 19 (83%, 75%, and 
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71% yield), respectively, which upon hydrogenation furnished respectively quercetin analogs 5, 
6, and 7  (61%, 58%, and 70% yield) (Scheme 1).  Compounds 12 and 13 are known and were 
prepared from a modified procedure of benzylation of gallic acid (20) and 2,5-dihydroxybenzoic 
acid (21), respectively, with sodium hydride (or sodium carbonate) and benzyl bromide in 
DMF
13,15
 followed by basic hydrolysis with sodium hydroxide (Scheme 1).  Carboxylic acids 22 
and 23 were similarly tetrabenzylated and hydrolyzed to give benzylated arylcarboxylic acids 14 
and 15 in 76% and 87% overall yield, respectively. 
To access quercetin analogs containing C3’-O- and C5-O-substituents, we prepared 
hydroxyl-protected quercetins, compounds 28 and 29, as described previously
16
 from 1 and 
sodium carbonate and 3 equiv. of benzyl chloride in DMF (Scheme 2).  A mixture of tribenzyl 
28 (63% yield) and tetrabenzyl 29 (18 % yield) were isolated after column chromatographic 
separation.  As mentioned above, due to intramolecular hydrogen bonding, C5-hydroxyl function 
is less reactive toward an electrophile than C3’-hydroxyl, hence selective esterification of 28 
with tribenzyl gallic acid 12, EDC, and DMAP afforded C3’-gallic ester 30.  Deprotection of the 
benzyl ether functions of 30 with hydrogen and palladium gave quercetin C3’-gallate 8 (Scheme 
2).  
Selective C3’-alkylation can similarly be carried out.  Hence, alkylation of 28 with 
sodium hydride and N-(3-iodopropyl)phthalimide (31)
17,18
 gave compound 32 (40% yield), 
which was subjected to reduction with hydrazine followed by hydrogen and palladium afforded 
3-aminopropyl quercetin 9 (49% overall yield).  The structure of compound 32 was 
unequivocally determined by a single-crystal x-ray analysis (Figure 2).
18
  The crystal is triclinic, 
space group of P-1, and the R factor of 0.051.  A mole of water was revealed in the crystal 
structure of 32. 
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Among five hydroxyl moieties, C5-hydroxyl function is the least reactive hydroxyl group 
of quercetin.  We were unable to esterify C5-hydroxyl function of tetrabenzyl protected quercetin 
29 with either tribenzyl protected gallic acid 12 or tribenzyl protected galloyl chloride and 
pyridine or sodium hydride at elevated temperature.  Likely, the bulky 3,4,5-tribenzyloxybenzoyl 
group could not fit into the C5-hydroxyl function.  However, smaller electrophiles such as allyl 
bromide can be attached to C5-hydroxyl group of 29.  Alkylation of quercetin 29 with sodium 
hydride and allyl bromide gave C5-O-allyl quercetin 33 in 88% yield, which upon reduction with 
hydrogen and palladium furnished C5-O-propyl derivative 10 (90% yield).  Allyl bromide was 
chosen as the alkylating agent instead of propyl iodide because a higher yield was produced. 
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Scheme 2.  Syntheses of quercetin C3' and C5 analogs
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Figure 2.  An ORTEP drawing of X-ray crystallographically determined structure of compound 
32. 
 
The inhibition of influenza A virus (A/swine/OH/511445/2007[H1N1], Oh7) by 
compounds 1 – 10 and 29 was evaluated following a procedure reported previously.7 In brief, 
Madin-Darby canine kidney (MDCK) cells were infected with influenza virus Oh7 and incubated 
with each compound at various concentrations from 0.1 – 150 M in the presence of trypsin (10 
g/mL) for up to 4 days.  Cytopathic effects (CPE) of the cells were observed for each 
compound. The effective doses for 50% virus reduction (ED50) and toxic doses at 50% cell death 
(TD50) of the above compounds are summarized in Table 1.  Viral replication was also confirmed 
by immunofluorescence assay and Western blot analysis with antibodies to the viral 
nucleoprotein or whole influenza virus, respectively.  Among the tested compounds, 
isoquercetin, EGCG, quercetin-3-gallate appear to have similar ED50 values against H1N1 virus, 
and isoquercetin (2) is the most active compound with a ED50 value of 1.2 M.  The ED50 of 
EGCG and quercetin-3-gallate was determined at 8 and 9.5 µM, respectively, and therapeutic 
index (TI) value of quercetin-3-gallate of 9.9 is slightly better than that of EGCG of 5.5.  C3-
Dihydroxyl and hydroxylaminobenzoate analogs, compounds 5 – 7, have ED50 values of 20 – 24 
M and similar TD50 values as that of EGCG indicating modification of the gallate moiety (of 
EGCG and quercetin-3-gallate) retains the anti-influenza activity.  Quercetin (1), without gallate 
function, is less effective with ED50 and TD50 values of 48.2 and 83.4 M, respectively.  Despite 
having a gallate function at C3’, compound 8, and C3’-3-aminopropyloxy analog 9 and C5-
propyloxy compound 10 are not effective up to 50 M.  Benzylated analogs such as compound 
9 
 
29 are not effective up to 50 M. Therefore the TD50 values of compounds 8 – 10 and 29 were 
not determined.  It appears that derivatization of C3’ and C5 led to lower antiviral activity. 
  
Table 1.  Values of effective dose required to reduce the replication of virus by 50% (ED50) and 
toxic dose for 50% cell death (TD50) of various natural and synthetic compounds. 
 
Compound ED50 value in µM TD50 value in µM Therapeutic index (TI) 
Quercetin (1) 
Isoquercetin (2) 
EGCG (3) 
Quercetin-3-gallate (4) 
5 
6 
7 
8 
9 
10 
29 
48.2 
1.2 
8.3 
9.1 
19.4 
22.6 
24.1 
>50 
>50 
>50 
>50 
83.4 
45.1 
45.5 
90.2 
45.2 
60.1 
54.8 
ND* 
ND 
ND 
ND 
1.7 
37.6 
5.5 
9.9 
2.3 
2.7 
2.3 
- 
- 
- 
- 
 
* ND: not determined due to high ED50 values. Note: Quercetin, isoquercetin and EGCG were 
purchased from Sigma-Aldrich (St. Louis, MO). 
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In conclusion, various C3, C3’, and C5 substituted quercetins were synthesized and their 
anti-H1N1 activities were examined.  C3-Substituted quercetins were derived from a 
carbodiimide-activated coupling reaction of C3’,C4’,C7-O-tribenzyl-protected quercetin 11 and 
various arylcarboxylic acids, and C3’- and C5-substituted quercetins were synthesized from 
C3,C4’,C7-O-tribenzyl- and C3,C3’,C4’,C7-O-tetrabenzyl-protected quercetin, respectively.  
Subsequent global removal of benzyl protecting groups afforded substituted quercetins.  C5-
Esterification with gallic acid 12 failed, but alkylation was possible.  The synthetic sequence is 
short and amenable to large scale synthesis, and the synthesized C3-analogs have comparable 
antiviral activity as that of EGCG implying further modification at C3 is possible in improving 
efficacy. 
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Supplementary Materials 
 
Experimental Section. 
General Methods.  NMR spectra were obtained from a 400-MHz spectrometer (Varian Inc.), in 
CDCl3, unless otherwise indicated, and reported in ppm.  Infrared spectra were taken from a 
Nicolet 380 FT-IR instrument (Thermo Scientific) in solid forms and are reported in wave 
numbers (cm
-1
).  Low-resolution mass spectra were taken from an API 2000-triple quadrupole 
ESI-MS/MS mass spectrometer (from Applied Biosystems).  High-resolution Mass spectra were 
obtained from a LCT Premier (Waters Corp., Milford MA) time of flight mass spectrometer.  
The instrument was operated at 10,000 resolution (W mode) with dynamic range enhancement 
that attenuates large intensity signals.  The cone voltage was 60 eV.  Spectra were acquired at 
16666 Hz pusher frequency covering the mass range 100 to 1200 μ and accumulating data for 2 
seconds per cycle.  Mass correction for exact mass determinations was made automatically with 
the lock mass feature in the MassLynx data system.  A reference compound in an auxiliary 
sprayer is sampled every third cycle by toggling a “shutter” between the analysis and reference 
needles.  The reference mass is used for a linear mass correction of the analytical cycles.  
Chemicals such rutin, quercetin, and others were purchased from Fisher Scientific and Aldrich 
Chemical Co. 
2 
 
O-Tribenzylgallic acid (12).13  A mixture of 5.0 g (29 mmol) of gallic acid (20), 15 g (0.15 mol) 
of sodium carbonate, 16 g (0.12 mol) of benzyl chloride in 50 mL of dried DMF was stirred 
under argon at 25oC for 14 h, diluted with 100 mL of water, and extracted with chloroform.  The 
organic layer was washed three times with water, dried (MgSO4), concentrated, crystallized from 
hexanes to give 9.1 g (58% yield) of pure tetrabenzyl 24: 1H NMR δ 7.42-7.24 (22 H, m), 5.32 (2 
H, s), 5.12 (6 H, s); 13C NMR δ 166.2, 152.7, 142.7, 137.6, 136.9, 136.3, 128.8, 128.7, 128.4, 
128.4, 128.3, 128.2, 128.2, 127.7, 125.3, 109.5, 75.3, 71.5, 67.0. 
A solution of 2.0 g (3.5 mmol) of compound 24, 0.3 g (7.0 mmol) of sodium hydroxide in 45 mL 
of methanol, water, and dioxane (1:1:1) was stirred under reflux for 14 h, cooled to 25oC, 
acidified with 1 N HCl, and extract with chloroform.  The chloroform extract was washed with 
water and brine, dried (MgSO4), concentrated, and crystallized from dichloromethane and diethyl 
ether to give 1.31 g (78% yield) of pure 1213 as a white solid, mp 190 – 195oC; 1H NMR δ 7.43 – 
7.27 (m, 17 H), 5.15 (s, 4 H, CH2), 5.14 (s, 2 H, CH2); 13C NMR δ 152.8, 137.6, 136.7, 128.8, 
128.7, 128.4, 128.3, 128.2, 127.8, 109.8, 75.4, 71.4. 
7-(Benzyloxy)-2-[3,4-bis(benzyloxy)phenyl]-5-hydroxy-4-oxo-4H-chromen-3-yl 3,4,5-
tris(benzyloxy)benzoate (16).    A mixture of 0.10 g (0.17 mmol) of 3’,4’,7-tri-O-
benzylquercetin (11), 72 mg (0.16 mmol) of O-tribenzylgallic acid (12), 27 mg (0.17 mmol) of 
EDC, and 4 mg of DMAP was dried under vacuum and maintained under argon.  To it, 8 mL of 
CH2Cl2 was added, and the resulting solution was stirred at 25oC for 12 h.  The reaction mixture 
was diluted with 20 mL of CH2Cl2, washed three times with water (30 mL each) and brine, dried 
(MgSO4), concentrated, and column chromatographed on silica gel using a gradient mixture of 
hexane and diethyl ether as eluent to give 0.11 g (64% yield) of compound 16 as a white solid, 
mp 98 – 99oC.  1H NMR δ 12.20 (s, 1 H, OH), 7.57 (s, 2 H), 7.48 – 7.27 (m, 32 H), 6.92 (d, J = 
3 
 
8.6 Hz, 1 H), 6.54 (d, J = 2.2 Hz, 1 H), 6.48 (d, J = 2.2 Hz, 1 H), 5.21 (s, 2 H), 5.16 (s, 2 H), 5.15 
(s, 2 H), 5.13 (s, 2 H), 5.12 (s, 2 H), 4.99 (s, 2 H); 13C NMR δ 176.0, 165.11, 163.65, 162.20, 
157.16, 156.35, 151.98, 148.76, 143.79, 137.51, 136.72, 136.66, 136.59, 135.86, 131.48, 128.99, 
128.86, 128.77, 128.70, 128.65, 128.46, 128.31, 128.25, 128.06, 127.81, 127.73, 127.48, 127.31, 
123.32, 122.81, 122.40, 114.62, 114.01, 110.20, 105.87, 99.24, 93.71, 75.43, 71.58, 71.02, 70.76.  
MS (electrospray) m/z 1017.7 (M+Na+), 903.6, 518.5; HRMS calcd for C64H51O11+ (M+H+) 
995.3431, found 995.3445. 
Quercetin 3-gallate [or 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 
3,4,5-trihydroxybenzoate] (4).11 A mixture of 0.11 g (0.11 mmol) of Compound 16, 11 mg of 
10% palladium on carbon in 5 mL each of methanol, dichloromethane, and ethyl acetate was 
stirred under hydrogen atmosphere at 25oC for 10 h.  The mixture was filtered through Celite and 
concentrated to give 50 mg (68% yield) of compound 4 as a solid, mp >270oC;11 1H NMR 
(DMSO-d6) δ 12.20 (bs, 1 H, OH), 9.30 (bs, 6 H, OH), 7.36 (d, J = 2.0 Hz, 1 H), 7.26 (dd, J = 
8.5, 2.0 Hz, 1 H), 6.28 (d, J = 1.8 Hz, 1 H), 7.12 (s, 1 H), 6.91 (s, 1 H), 6.87 (d, J = 8.5 Hz, 1 H), 
6.54 (d, J = 1.8 Hz, 1 H); 13C NMR δ 175.77, 165.29, 164.00, 161.74, 157.28, 156.75, 149.89, 
146.46, 146.35, 146.19, 146.16, 140.36, 130.61, 121.08, 120.44, 117.89, 116.43, 115.74, 110.05, 
104.13, 99.71, 94.72; MS (electrospray) m/z 477.2 (M+Na+; 100%), 413.4.  HRMS calcd for 
C22H15O11+ (M+H+) 455.0614, found 455.0589. 
Benzyl 2,5-dibenzyloxybenzoate (25).  To a solution of 1.0 g (6.4 mmol) of 2,5-
dihydroxybenzoic acid, 3.6 g (26 mmol) of potassium carbonate in 25 mL of DMF under argon 
at 25oC, was added 3.6 g (21 mmol) of benzyl bromide via syringe.  The solution was stirred at 
60oC for 12 h, cooled to 25oC, diluted with aqueous ammonium chloride, and extracted with 
dichloromethane.  The organic layer was washed with water three time, and brine, dried 
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(MgSO4), concentrated, and column chromatographed on silica gel using a gradient mixture of 
hexane and diethyl ether as eluent to give 2.8 g (87% yield) of compound 25.15  1H NMR δ 7.48 
(d, J = 3.2 Hz, 1 H), 7.42 - 7.25 (m, 15 H), 7.05 (dd, J = 8.8, 3.2 Hz, 1 H), 6.94 (d, J = 8.8 Hz, 1 
H), 5.34 (s, 2 H), 5.09 (s. 2 H), 5.02 (s, 2 H); 13CNMR δ 166.2, 152.9, 152.7, 137.1, 137.0,  
128.8, 128.7, 128.7, 128.4, 128.3, 128.3, 128.0, 127.8, 127.4, 121.7, 120.6, 117.7, 72.0, 70.9, 
67.1. 
2,5-Dibenzyloxybenzoic acid (13).14,15 A solution of 1.0 g (2.4 mmol) of ester 25 and 0.19 g 
(4.7 mmol) of sodium hydroxide in 15 mL of methanol, dioxane, and water (1:1:1) was stirred 
under reflux for 14 h, cooled to 25oC, and most of the organic solvents were removed from a 
rotary evaporator.  The residue was diluted with water, acidified with 1 N HCl, extracted twice 
with ethyl acetate (50 mL), and the ethyl acetate layers were combined, washed with water and 
brine, dried (MgSO4), concentrated, and column chromatographed using a mixture of hexane and 
ethyl acetate (1:1) as eluent to give 0.72 g (91% yield) of compound 13.15  1H NMR δ 11.06 (s, 1 
H), 7.81 (d, J = 3.1 Hz, 1 H), 7.43 - 7.32 (m, 10 H), 7.17 (dd, J = 9.0, 3.1 Hz, 1 H), 7.07 (d, J = 
9.0 Hz, 1 H), 5.26 (s, 2 H), 5.08 (s, 2 H); 13C NMR δ 165.3, 153.9, 151.9, 136.6, 134.6, 129.4, 
129.4, 128.8, 128.4, 128.2, 127.8, 123.0, 119.0, 117.8, 115.1, 73.2, 70.9.  
2-(3,4-Dibenzyloxyphenyl)-7-benzyloxy-5-hydroxy-4-oxo-4H-chromen-3-yl 2,5-
dibenzyloxybenzoate (17).  To a solution of 50 mg (0.15 mmol) of 2,5-dibenzyloxybenzoic acid 
(13), 27 mg (0.15 mmol) of EDC, and 4 mg (3 μmol) of DMAP in 3 mL of dichloromethane 
under argon at 25oC was added a solution of 50 mg (87 μmol) of 3’,4’,7-tri-O-benzylquercetin 
(11) in 5 mL of dichloromethane via syringe.  The reaction mixture was stirred at 25oC for 12 h, 
diluted with 50 mL of water, and extracted three times with 15 mL each of dichloromethane.  
The combined organic layer was washed with brine, dried (anhydrous MgSO4), concentrated, 
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and column chromatographed on silica gel using a mixture of 1:1 hexane and diethyl ether as 
eluent to give 65 mg (83% yield) of 17 as a white solid, mp 85 - 88oC.  1H NMR δ 12.3 (s, 1 H, 
OH), 7.79 (d, J = 3.6 Hz, 1 H), 7.56 (d, J = 2.0 Hz, 1 H), 7.53 (dd, J = 8.6, 2 Hz, 1 H), 7.46 - 
7.22 (m, 25 H), 7.15 (dd, J = 9.0, 3.6 Hz, 1 H), 7.00 (d, J = 9.0 Hz, 1 H), 6.88 (d, J = 8.2 Hz, 1 
H), 6.54 (d, J = 2.0 Hz, 1 H), 6.48 (d, J = 2.0 Hz, 1 H), 5.16 (s, 2 H), 5.15 (2, 2 H), 5.12 (s, 2 H) 
5.04 (s, 2 H), 4.97 (s, 2 H); 13C NMR δ 176.1, 165.1, 162.8, 162.3, 157.2, 156.5, 154.1, 152.9, 
151.9, 148.8, 136.9, 136.8, 136.7, 136.0, 131.5, 129.0, 128.9, 128.8, 128.7, 128.6, 128.3, 128.25, 
128.2, 128.0, 127.9, 127.8, 127.6, 127.4, 127.34, 127.32, 123.0, 122.6, 122.3, 119.2, 118.4, 
116.8, 114.8, 114.0, 106.0, 99.2, 93.7, 72.1, 71.5, 71.03, 71.01, 70.8.  MS (electrospray) m/z 
889.5 (M+H+; 100%), 413.2.  HRMS calcd for C57H45O10 (M+H+) 889.3013, found 889.3035. 
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 2,5-dihydroxybenzoate (5).  
A mixture of 50 mg (56 μmol) of compound 17 and 5 mg of 10% palladium/carbon in 9 ml of 
ethyl acetate, methanol and dichloromethane (1:1:1) was shaken at 25oC under 25 psi hydrogen 
atmosphere for 10 h. The reaction mixture was diluted with 10 mL of methanol and filtered 
through Celite, and the filtrate was concentrated to give 15 mg (60% yield) of 5 as a solid, mp 
>270oC.  1H NMR (DMSO-d6) δ 12.14 (s, OH, 1 H), 11.08 (bs, OH, 1 H), 9.98 (bs, OH, 1 H), 
9.59 (s, OH, 1 H), 9.48 (bs, OH, 1 H), 9.35 (s, OH, 1 H), 7.36 - 7.28 (m, 3 H), 7.06 (dd, J = 8.8, 
2.8 Hz, 1 H), 6.89 (dd, J = 13.6, 8.4 Hz, 1 H), 6.51 (d, J = 1.2 Hz, 1 H), 6.27 (d, J = 1.6 Hz, 1 H);  
13C NMR (DMSO-d6) δ 175.3, 165.4, 161.7, 157.3, 156.9, 154.1, 150.4, 150.1, 146.2, 130.1, 
125.4, 121.2, 120.5, 120.1, 119.3, 116.5, 115.8, 115.7, 112.5, 104.0, 99.8, 94.8.  MS 
(electrospray) m/z 461.1 (M+Na+; 100%), 325.3.  HRMS calcd for C22H15O10 (M+H+) 439.0665, 
found 439.0663. 
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Benzyl 4-(benzyloxy)-3-(dibenzylamino)benzoate (26). To a solution of 1.0 g (6.5 mmol) of 3-
amino-4-hydroxybenzoic acid (22) and 0.71 g (29 mmol) of sodium hydride (50% oil, which was 
removed by washing with dried diethyl ether twice) in 20 mL of DMF under argon at 25oC was 
added 3.9 mL (33 mmol) of benzyl bromide.  The reaction solution was stirred at 60oC for 14 h, 
cooled to 25oC, diluted with 50 mL of aqueous NH4Cl, and extracted with dichloromethane.  The 
organic layer was washed three times with water, and brine, dried (MgSO4), concentrated, and 
column chromatographed on silica gel using a gradient mixture of hexane and diethyl ether to 
give 3.1 g (90% yield) of 26: Mp 109 – 110oC;  1H NMR δ 7.66 (dd, J = 8.4, 2.1 Hz, 1 H), 7.60 
(d, J = 2.0 Hz, 1 H), 7.42 (dd, J = 8.0, 2.0 Hz, 2 H), 7.37 - 7.16 (m, 18 H), 6.91 (d, J = 8.4 Hz, 1 
H), 5.26 (s, CH2O, 2 H), 5.19 (s, CH2O, 2 H), 4.25 (s, CH2N, 4 H); 13C NMR δ 166.5, 156.5, 
140.0, 138.9, 136.7, 136.6, 128.8, 128.7, 128.3, 128.3, 128.2, 128.1, 127.7, 127.0, 125.2, 123.4, 
122.8, 112.5, 70.8, 66.5, 55.9.  MS (electrospray) m/z 514.3 (M+H+), 536.4 (M+Na+), 332.3.  
HRMS calcd for C35H32NO3+ (M+H+) 514.2382, found 514.2362. 
4-(Benzyloxy)-3-(dibenzylamino)benzoic acid (14).  A solution of 1.5 g (2.9 mmol) of 
benzoate 26 and 0.23 g (5.9 mmol) of sodium hydroxide in 15 mL of methanol, dioxane, and 
water (1:1:1) was stirred under reflux for 3 h, cooled to 25oC, and acidified with 5 mL of 1 N 
HCl.  The solution was extracted with 50 mL of ethyl acetate, and the organic extract was 
washed three times with water (20 mL each), and brine, dried (MgSO4), concentrated, and 
column chromatographed on silica gel using a mixture of hexane and diethyl ether (7:3) to give 
0.70 g (84% yield) of acid 14: Mp 177 – 180oC; 1H NMR δ 4.26 (s, 4 H) 5.24 (s, 2 H) 6.97 (d, J 
= 8.4 Hz, 1 H) 7.14 - 7.49 (m, 15 H) 7.61 (s, 1 H) 7.70 (d, J = 8.4 Hz, 1 H); 13C NMR δ 172.0, 
157.1, 140.1, 138.7, 136.6, 128.8, 128.7, 127.7, 127.1, 126.0, 123.9, 121.8, 112.5, 70.9, 55.8.  
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MS (electrospray) m/z 424.4 (M+H+; 100%), 446.2 (M+Na+), 242.5.  HRMS calcd for 
C28H26NO3+ (M+H+) 424.1913, found 424.1899. 
7-(Benzyloxy)-2-(3,4-dibenzyloxyphenyl)-5-hydroxy-4-oxo-4H-chromen-3-yl 4-(benzyloxy)-
3-(dibenzylamino)benzoate (18).  To a solution of 0.15 g (0.35 mmol) of acid 14, 55 mg (0.35 
mmol) of EDC, 9 mg (7 μmol) of DMAP in 3 mL of dichloromethane under argon at 25oC was 
added a solution of 0.14 g (0.24 mmol) of benzyl quercetin 11 in 5 mL of dichloromethane.  The 
solution was stirred for 14 h, diluted with water and extracted with dichloromethane (30 mL).  
The organic extract was washed with water and brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using a gradient mixture of hexane and diethyl ether as eluent to 
give 0.18 g (75% yield) of 18 as a solid, mp 114 – 115oC.  1H NMR δ 12.25 (s, 1 H, OH), 7.85 
(dd, J = 8.6, 2.0 Hz, 1 H), 7.78 (d, J = 2.0 Hz, 1 H), 7.12 - 7.48 (m, 32 H), 7.00 (d, J = 8.6 Hz, 1 
H), 6.90 (d, J = 9.4 Hz, 1 H), 6.53 (d, J = 1.6 Hz, 1 H), 6.47 (d, J = 2.0 Hz, 1 H), 5.20 (s, 2 H), 
5.19 (s, 2 H), 5.15 (s, 2 H), 4.81 (s, 2 H), 4.27 (s, 4 H, CH2N); 13C NMR δ 176.3, 165.0, 163.9, 
162.3, 157.4, 157.2, 156.2, 151.8, 148.8, 140.6, 138.8, 136.9, 136.7, 136.4, 135.9, 131.5, 129.0, 
128.9, 128.8, 128.7, 128.6, 128.4, 128.37, 128.3, 128.1, 127.8, 127.7, 127.5, 127.3, 127.1, 126.2, 
123.9, 122.7, 122.6, 120.8, 114.5, 114.1, 112.7, 106.0, 99.2, 93.6, 71.3, 71.1, 71.0, 70.8, 55.8 (2 
C’s).  MS (electrospray) m/z 1000.6 (M+Na+), 978.6 (M+H+), 224.0 (100%).  HRMS calcd for 
C64H52NO9+ (M+H+) 978.3642, found 978.3681. 
5,7-Dihydroxy-2-(3,4-dihydroxyphenyl)-4-oxo-4H-chromen-3-yl 4-hydroxy-3-
aminobenzoate (6).  A mixture of 66 mg (0.07 mmol) of compound 18, 20 mg of 10% 
palladium over carbon in 9 mL of ethyl acetate, methanol, and dichloromethane (1:1:1) was 
shaken in a hydrogenator under 36 psi of hydrogen at 25oC for 14 h.  The mixture was diluted 
with 20 mL of methanol and filter through Celite, concentrated to dryness to give 17 mg (58% 
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yield) of 6 as a solid, mp >270oC. 1H NMR (DMSO-d6) δ 12.19 (s, 1 H, OH), 11.17 (bs, 1 H, 
OH), 9.93 (bs, 1 H), 9.47 (bs, 1 H), 7.93 (s, 1 H), 7.75 (d, J = 7.6 Hz, 1 H), 7.39 (d, J = 2.4 Hz, 1 
H),  7.27 (dd, J = 8.4, 2.0 Hz, 1 H), 7.11 (d, J = 8.8 Hz, 1 H), 6.88 (d, J = 8.4 Hz, 1 H), 6.55 (d, J 
= 2.4 Hz, 1 H), 6.29 (d, J = 1.6 Hz, 1 H); 13C NMR (DMSO-d6) δ 176.0, 165.2, 164.0, 161.8, 
157.3, 156.7, 149.8, 146.1, 143.8, 143.7, 130.7, 124.6, 121.1, 120.6, 116.4, 115.8, 115.7, 115.0, 
113.6, 104.2, 99.6, 94.6.  MS (electrospray) m/z 438.3 (M+H+), 136.1 (100%).  HRMS calcd for 
C22H16NO9+ (M+H+) 438.0825, found 438.0810. 
Phenyl 3-(benzyloxy)-4-(dibenzylamino)benzoate (27).  A mixture of 1.0 g (6.5 mmol) of 4-
amino-3-hydroxybenzoic acid (23) and 0.7 g (27 mmol) of sodium hydride was dried under 
vacuum and maintained under argon. To it 5 mL of dried DMF was added and the solution was 
stirred at 25oC for 0.5 h.  To the reaction solution, 3.1 mL (26 mmol) of benzyl bromide was 
added, and the resulting solution was stirred at 80oC for 16 h, cooled to 25oC, and 20 mL of 
saturated aqueous NH4Cl was added. The mixture was extracted with 100 mL of ethyl acetate, 
and the organic layer was washed with 50 mL of water three times and brine, dried (anhydrous 
MgSO4),  concentrated, and column chromatographed on silica gel using a mixture of 5:1 hexane 
and ethyl acetate as eluent to give 3.0 g (90% yield) of 27 as white solid, mp 105 – 107oC.  1H 
NMR δ 7.67 (d, J = 2.0 Hz, 1 H), 7.55 (dd, J = 6.4, 2.0 Hz, 1 H), 7.42 - 7.16 (m, 20 H), 6.76 (d, J 
= 8.8 Hz, 1 H), 5.31 (s, CH2O, 2 H), 5.18 (s, CH2O, 2 H), 4.40 (s, CH2N, 4 H). 13C NMR δ 166.5, 
156.4, 139.9, 138.8, 136.6, 129.4, 128.8, 128.7, 128.7, 128.3, 128.23, 128.20, 128.1, 127.7, 
127.0, 125.1, 123.3, 122.6, 112.4, 70.7, 66.4, 55.8; MS (electrospray) m/z 514.3 (M+H+; 100%), 
536.4 (M+Na+), 332.1.  HRMS calcd for C35H32NO3+ (M+H+) 514.2382, found 514.2394. 
3-(Benzyloxy)-4-(dibenzylamino)benzoic acid (15).  A mixture of 1.0 g (2.0 mmol) of 27 and 
0.16 g (4.0 mmol) of sodium hydroxide in 15 mL of methanol, dioxane, and water (1:1:1) was 
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stirred under reflux for 3 h, cooled to 25oC, acidified with 5 mL of 1 N HCl, and extracted with 
50 mL of ethyl acetate.  The organic layer was washed three times with 20 mL of water, and 
brine, dried (MgSO4), concentrated, and column chromatographed on silica gel using a gradient 
mixture of hexane and diethyl ether as eluent to give 0.8 g (97% yield) of acid 15 as white solid, 
mp 185 – 187oC. 1H NMR δ 7.70 (s, 1 H), 7.59 (d, J = 8.2 Hz, 1 H), 7.14 - 7.44 (m, 15 H), 6.80 
(d, J = 8.2 Hz, 1 H), 5.19 (s, 2 H, CH2O), 4.44 (s, 4 H, CH2N); 13C NMR δ 172.2, 150.5, 145.8, 
138.4, 136.7, 128.7, 128.5, 128.2, 128.17, 128.0, 127.1, 124.6, 121.5, 119.5, 114.7, 71.1, 55.3; 
MS (electrospray) m/z 424.4 (M+H+, 100%).  HRMS calcd for C28H26NO3+ (M+H+) 424.1913, 
found 424.1914. 
7-(Benzyloxy)-2-(3,4-dibenzyloxyphenyl)-5-hydroxy-4-oxo-4H-chromen-2-yl 3-(benzyloxy)-
4-(dibenzylamino)benzoate (19).  To a solution of 48 mg (0.11 mmol) of 15, 18 mg (0.11 
mmol) of EDC, and 2 mg (18 μmol) of DMAP in 3 mL of dichloromethane under argon at 25oC 
was added a solution of 50 mg (87 μmol) tribenzyl quercetin 11 in 5 mL of dichloromethane.  
The reaction solution was stirred for 12 h, diluted with 50 mL of water, and extracted three times 
with dichloromethane (15 mL each).  The combined organic layer was washed with brine, dried 
(MgSO4), concentrated, and column chromatographed on silica gel using a mixture of hexane 
and diethyl ether (1:1) as eluent to give 60 mg (71% yield) of compound 19 as white solid, mp. 
110 – 112oC;  1H NMR δ 12.22 (s, 1 H, OH), 7.79 (d, J = 1.6 Hz, 1 H), 7.73 (dd, J = 8.4, 1.8 Hz, 
1 H), 7.47 - 7.54 (m, 2 H), 7.14 - 7.45 (m, 30 H), 6.92 (d, J = 8.6 Hz, 1 H), 6.82 (d, J = 8.6 Hz, 1 
H), 6.51 (d, J = 2.0 Hz, 1 H), 6.43 (d, J = 2.0 Hz, 1 H), 5.16 (s, 2 H), 5.13 (s, 2 H), 5.10 (s, 2 H), 
4.93 (s, 2 H), 4.44 (s, 4 H, CH2N); 13C NMR δ 176.7, 164.9, 163.86, 162.1, 157.1, 156.1, 151.7, 
150.5, 148.5, 146.1, 138.2, 136.7, 136.6, 136.4, 135.8, 131.5, 128.9, 128.7, 128.6, 128.5, 128.2, 
128.17, 128.14, 128.1, 128.0, 127.9, 127.7, 127.4, 127.2, 127.1, 125.0, 122.6, 122.5, 119.9, 
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119.3, 114.9, 114.4, 113.8, 105.8, 99.1, 93.5, 71.3, 71.1, 70.9, 70.6, 55.2.  MS (electrospray) m/z 
1000.6 (M+Na+), 978 (M+H+), 224.0 (100%).  HRMS calcd for C64H52NO9+ (M+H+) 978.3642, 
found 978.3681. 
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 4-amino-3-
hydroxybenzoate (7).  A mixture of 0.1 g (0.1 mmol) of 19 and 40 mg of 10% palladium over 
carbon in 9 mL of ethyl acetate, methanol, and dichloromethane (1:1:1) was shaken at 25oC 
under 36 psi hydrogen atmosphere for 10 h.  After removal from the hydrogenator, the mixture 
was diluted with 10 mL of methanol, filtered through Celite, concentrated to give a solid. This 
solid was washed with dichloromethane and vacuum dried to obtain 31 mg (70% yield) of 7 as a 
light yellow solid, mp >270oC (dec.). 1H NMR (DMSO-d6) δ 7.44 (dd, J = 8.3, 1.9 Hz, 1 H), 
7.35 (dd, J = 8.3, 2.0 Hz, 2 H), 7.27 (dd, J = 8.3, 2.0 Hz, 1 H), 6.84 (d, J = 8.3 Hz, 1 H), 6.69 (d, 
J = 8.3 Hz, 1 H), 6.49 (d, J = 2.0 Hz, 1 H), 6.25 (d, J = 2.0 Hz, 1 H); 13C NMR (DMSO-d6) δ 
176.0, 165.2, 164.0, 161.8, 157.3, 156.7, 149.8, 146.1, 143.8, 143.7, 130.7, 124.6, 121.1, 120.6, 
116.4, 115.8, 115.7, 115.0, 113.6, 104.2, 99.6, 94.6.  MS (electrospray; negative mode) m/z 
436.4 (M-H+), 255.4.  HRMS calcd for C22H16NO9+ (M+H+) 438.0825, found 438.0816. 
3,7-(Dibenzyloxy)-2-(4-benzyloxy-3-hydroxyphenyl)-5-hydroxy-4-oxo-4H-chromene (28) 
and 3,7-(dibenzyloxy)-2-(3,4-dibenzyloxyphenyl)-5-hydroxy-4-oxo-4H-chromene (29).16 To 
a solution of 1.0 g (3.3 mmol) of quercetin (1) and 1.0 g (9.9 mmol) of sodium carbonate in 30 
mL of DMF under argon at 80oC was added 1.3 g (9.9 mmol) of benzyl chloride via syringe.  
The solution was stirred at 80oC for 20 h and most of the DMF solvent was removed via vacuum 
distillation at 50 – 60oC/5 mm Hg.  The remaining mixture was diluted with dichloromethane, 
washed with 2 N HCl, water, and brine, dried (anhydrous Na2SO4), concentrated, and column 
chromatographed on silica gel using a gradient mixture of hexane and ethyl acetate as eluent to 
11 
 
give 1.2 g (63% yield) of compound 28 and 0.4 g (18% yield) of compound 29.  Compound 28:16 
Mp 146 – 149oC;  1H NMR δ 12.71 (s, 1 H, OH), 7.65 (d, J = 2 Hz, 1 H), 7.63 (s, 1 H), 7.46 – 
7.22 (m, 15 H), 6.97 (d, J = 9 Hz, 1 H), 6.51 (d, J = 2 Hz, 1 H), 6.45 (d, J = 2 Hz, 1 H), 5.72 (s, 1 
H, OH), 5.21 (s, 2 H), 5.14 (s, 2 H), 5.08 (s, 2 H); 13C NMR δ 179.0, 164.7, 162.2, 157.0, 156.5, 
148.0, 145.8, 137.8, 136.0, 135.9, 129.0, 128.5, 127.7, 124.2, 122.1, 115.1, 111.8, 98.9, 93.2, 
74.5, 71.4, 70.6.  Compound 29:16 Mp 110 – 114oC; 1H NMR δ 12.70 (s, 1 H, OH), 7.72 (d, J = 2 
Hz, 1 H), 7.56 (dd, J = 9, 2 Hz, 1 H), 7.50 – 7.20 (m, 20 H), 6.98 (d, J = 9 Hz, 1 H), 6.48 (d, J = 
2 Hz, 1 H), 6.45 (d, J = 2 Hz, 1 H), 5.26 (s, 2 H), 5.15 (s, 2 H), 5.06 (s, 2 H), 5.01 (s, 2 H); 13C 
NMR δ 179.0, 164.7, 162.3, 156.9, 156.5, 151.3, 148.4, 137.7, 136.9, 136.7, 136.0, 129.0, 128.7, 
128.5, 127.7, 127.4, 123.7, 122.8, 115.5, 113.9, 106.4, 98.8, 93.3, 74.6, 71.3, 71.1, 70.7.   
5-(3,7-Bis(benzyloxy)-5-hydroxy-4-oxo-4H-chromen-2-yl)-2-(benzyloxy)phenyl 3,4,5-
tris(benzyloxy)benzoate (30).  To a solution of 0.12 g (0.26 mmol) of acid 12, 40 mg (26 mmol) 
of EDC and 4 mg (35 μmol) of DMAP in 2 mL of dichloromethane under argon was added a 
solution of 0.10 g (0.17 mmol) of compound 28.  The reaction solution was stirred at 25oC for 12 
h, diluted with 50 mL of dichloromethane, washed three times with water, and brine, dried 
(anhydrous Na2SO4), concentrated and column chromatographed on silica gel using a gradient 
mixture of hexane and diethyl ether as eluent to give 60 mg (35% yield) of compound 30.  1H 
NMR δ 12.7 (s, 1 H, OH), 7.94 (d, J = 2.0 Hz, 1 H), 7.92 (s, 1 H), 7.56 (s, 2 H), 7.46 - 7.18 (m, 
30 H), 7.04 (d, J = 9.2 Hz, 1 H), 6.50 (d, J = 2.0 Hz, 1 H), 6.44 (d, J = 2.0 Hz, 1 H), 5.19 (s, 2 
H), 5.17 (s, 2 H), 5.15 (s, 4 H), 5.12 (s, 2 H), 5.11 (s, 2 H); 13C NMR δ 179.0, 164.8, 164.4, 
162.3, 156.9, 155.6, 151.9, 151.6, 143.3, 140.4, 137.9, 137.6, 136.8, 136.4, 136.3, 136.0, 129.2, 
129.0, 128.8, 128.77, 128.6, 128.54, 128.51, 128.45, 128.32, 128.26, 128.24, 128.0, 127.8, 127.7, 
127.6, 127.4, 127.1, 124.4, 123.9, 123.7, 113.8, 110.0, 106.4, 98.9, 93.3, 75.4, 74.7, 71.6, 70.8, 
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70.7.  MS (electrospray) m/z 995.9 (M+H+).  HRMS calcd for C64H51O11+ (M+H+) 995.3431, 
found 995.3475. 
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl 3,4,5-trihydroxybenzoate 
(8).  A mixture of 55 mg (55 μmol) of compound 30 and 11 mg of 5% palladium over carbon in 
11 mL of ethyl acetate, methanol, and dichloromethane (5:3:3) was shaken in a hydrogenator 
under 36 psi pressure of hydrogen at 25oC for 16 h.  The reaction mixture was diluted with 
ethanol and filtered through Celite, concentrated to dryness to give a solid.  The solid was 
washed with 5 mL of water and 15 mL of diethyl ether, and dried under vacuum to give 14 mg 
(56% yield) of C3’-gallate 8.  1H NMR (DMSO-d6) δ 12.40 (s, 1 H, OH), 9.10 - 9.90 (bs, 5 H, 
OH), 7.96 (dd, J = 8.6, 2.2 Hz, 1 H), 7.91 (d, J = 2.4 Hz, 1 H), 7.10 (s, 3 H), 6.47 (d, J = 1.6 Hz, 
1 H), 6.19 (d, J = 2.0 Hz, 1 H); 13C NMR δ 176.6, 164.9, 164.8, 164.7, 161.3, 156.8, 151.8, 
149.7, 146.4, 146.3, 139.8, 139.2, 137.7, 136.7, 123.5, 122.7, 118.9, 117.5, 109.9, 109.9, 103.7, 
99.0.  MS (electrospray) m/z 477.1 (M+Na+), 455.2 (M+H+).  HRMS calcd for C22H15O11+ 
(M+H+) 455.0614, found 455.0609. 
3,7-(Dibenzyloxy)-2-[4-benzyloxy-3-(3-phthaloylpropyloxy)phenyl]-5-hydroxy-4-oxo-4H-
chromene (32).  A solution of 1.1 g (1.9 mmol) of compound 28, 0.73 g (2.3 mmol) of 3-
iodopropylphthalimide (31),17,18 and 92 mg (3.9 mmol) of sodium hydride (50% oil) in 20 mL of 
DMF was stirred under argon at 80oC for 48 h.  The reaction solution was cooled to 25oC, diluted 
with aqueous NH4Cl, and extracted three times with ethyl acetate.  The organic layer was washed 
with water and brine, dried (MgSO4), concentrated, and column chromatographed on silica gel 
using a gradient mixture of hexane and ethyl acetate as eluent to give 0.58 g (40% yield) of 
compound 32.  Crystallization of 32 in ethyl acetate and hexane afforded single crystals suitable 
for X-ray analysis.  Mp 168 – 174oC; 1H NMR δ 12.70 (s, 1 H, OH), 7.81 (dd, J = 8, 2 Hz, 2 H), 
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7.67 (dd, J = 8, 2 Hz, 1 H), 7.63 (d, J = 2 Hz, 1 H), 7.57 (dd, J = 8, 2 Hz, 1 H), 7.45 – 7.23 (m, 
15 H), 6.91 (d, J = 8 Hz, 1 H), 6.55 (d, J = 2 Hz, 1 H), 6.44 (d, J = 2 Hz, 1 H), 5.14 (s, 2 H, 
CH2OPh), 5.13 (s, 2 H, CH2OPh), 5.07 (s, 2 H, CH2OPh), 3.88 (m, 4 H, CH2O & CH2N), 2.15 
(quin, J = 7 Hz, 2 H); 13C NMR δ 179.0, 168.5, 164.7, 162.3, 156.9, 156.5, 151.1, 148.6, 137.8, 
136.9, 134.1, 132.4, 129.0, 128.5, 127.7, 127.2, 123.7, 123.4, 122.7, 114.6, 113.9, 106.4, 98.8, 
93.3, 74.6, 70.9, 70.7, 67.0, 35.64, 28.64.  MS (electrospray) m/z 782.3 (M+Na+), 760.6 (M+H+), 
413.1 (100%).  HRMS calcd for C47H38NO9+ (M+H+) 760.2547, found 760.2571. 
3,5,7-(Trihydroxy)-2-[4-hydroxy-3-(3-aminopropyloxy)phenyl]-4-oxo-4H-chromene (9).  A 
solution of 100 mg (0.13 mmol) of phthalimide 32 and 99 mg (2.0 mmol) of hydrazine in 3 mL 
of THF was stirred under argon at 25oC for 11 h.  The solution was diluted with 50 mL of 
dichloromethane, precipitated white solids was removed by filtration, and the filtrate was washed 
twice with water and brine, dried (anhydrous Na2SO4), concentrated to give 70 mg (85% yield) 
of 3,7-(dibenzyloxy)-5-hydroxy-2-[4-benzyloxy-3-(3-aminopropyloxy)phenyl]-4-oxo-4H-
chromene.  1H NMR δ 7.50 – 7.10 (m, 17 H), 6.82 (d, J = 2 Hz, 2 H), 6.67 (d, J = 2 Hz, 1 H), 
6.40 (bs, 2 H), 6.22 (s, 1 H), 4.99, (s, 2 H, CH2O), 4.97 (s, 2 H, CH2O), 4.69 (s, 2 H, CH2O), 3.89 
(t, J = 7 Hz, 2 H, CH2O), 2.78 (t, J = 7 Hz, 2 H, CH2N), 1.80 (quin, J = 7 Hz, 2 H); 13C NMR δ 
178.9, 164.6, 162.2, 156.8, 156.5, 151.0, 148.7, 137.8, 136.8, 136.7, 135.9, 128.9, 128.8, 128.5, 
128.5, 128.4, 128.3, 127.7, 127.4, 123.5, 122.4, 114.2, 113.4, 106.3, 98.7, 93.2, 74.6, 70.9, 70.6, 
68.1, 67.7, 29.7.  MS (electrospray) m/z 630.3 (M+H+).  This material was used in next step 
without purification.  A mixture of 50 mg (79 μmol) of the above benzyl quercetin, 15 mg of 5% 
palladium over carbon in 2 mL each of THF and methanol along with 5 drops of 2 N HCl, was 
shaken in a hydrogenator under 36 psi hydrogen for 16 h at 25oC.  The mixture was diluted with 
10 mL of methanol, filter through Celite, concentrated to give 17 mg (58% yield) of compound 
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9.  1H NMR (DMSO-d6)  δ 12.45 (s, 1 H, OH), 10.81 (s, 1 H, OH), 9.74 (s, 1 H, OH), 9.46 (s, 
1H, OH), 7.75 (d, J = 2.0 Hz, 1 H), 7.71 (dd, J = 8.4, 2.0 Hz, 1 H), 6.98 (d, J = 8.4 Hz, 1 H), 6.47 
(d, J = 2.0 Hz, 1 H), 6.21 (d, J = 2.0 Hz, 1 H), 4.13 (t, J = 6.0 Hz, 2 H), 3.05 (bs, 2 H), 2.07 - 
2.03 (m, 2 H); 13C NMR δ 176.5, 164.7, 161.3, 156.8, 149.6, 147.1, 147.0, 136.5, 122.7, 122.67, 
116.4, 113.8, 103.7, 98.9, 94.3, 66.6, 37.2, 27.6.  HRMS calcd for C18H18NO7+ (M+H+) 
360.1083, found 360.1100.     
3,7-(Dibenzyloxy)-2-(3,4-dibenzyloxyphenyl)-5-allyloxy-4-oxo-4H-chromene (33).  To a 
solution of 54 mg (82 μmol) of compound 29 and 3 mg (0.12 mmol) of sodium hydride in 1 mL 
of DMF under argon at 25oC was added 12 mg (98 μmol) of allyl bromide via syringe.  The 
reaction solution was stirred for 10 h, diluted with dichloromethane, neutralized with 1 N HCl, 
washed three times with water, and brine, dried (MgSO4), concentrated, and column 
chromatographed on silica gel using 20% ethyl acetate in hexane as eluent to give 50 mg (88% 
yield) of compound 33 as a white solid, mp 107 – 110oC.  1H NMR δ 7.72 (d, J = 2.0 Hz, 1 H), 
7.54 (dd, J = 8.5, 2.0 Hz, 1 H), 7.46 - 7.21 (m, 20 H), 6.95 (d, J = 8.5 Hz, 1 H), 6.53 (d, J = 2.4 
Hz, 1 H), 6.42 (d, J = 2.4 Hz, 1 H), 6.13 - 6.08 (ddt, J = 17.6, 10.4, 6.4 Hz, 1 H, =CH), 5.64 (dd, 
J = 17.6, 1.6 Hz, 1 H, =CH2), 5.35 (dd, J = 10.4, 1.6 Hz, 1 H, =CH2), 5.23 (s, 2 H, CH2OPh), 
5.12 (s, 2 H, CH2OPh), 5.08 (s, 2 H, CH2OPh), 4.94 (s, 2 H, CH2OPh), 4.69 (d, J = 6.4 Hz, 2 H, 
CH2O); 13C NMR δ 174.1, 162.9, 160.1, 158.9, 153.2, 150.6, 148.4, 141.5, 140.0, 137.3, 137.2, 
137.0, 135.9, .132.5, 129.1, 129.0, 128.8, 128.6, 128.3, 128.2, 128.1, 128.0, 127.8, 127.6, 127.4, 
124.1, 122.2, 118.3, 115.3, 113.9, 110.1, 97.9, 93.8, 74.2, 71.2, 71.0, 70.7, 70.1.  MS 
(electrospray) m/z 725.5 (M+Na+, 100%), 703.4 (M+H+), 396.3.  HRMS calcd for C46H39O7+ 
(M+H+) 703.2696, found 703.2687. 
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3,7-(Dihydroxy)-2-(3,4-dihydroxyphenyl)-5-propyloxy-4-oxo-4H-chromene (10).  A mixture 
of 80 mg (0.11 mmol) of compound 33 and 30 mg of 10% palladium over carbon in 6 mL of 
ethyl acetate, acetone, and ethanol (1:1:1) was shaken in a hydrogenator under 36 psi of 
hydrogen at 25oC for 18 h.  The reaction mixture was diluted with ethanol and filtered through 
Celite, the filtrate was concentrated to dryness giving 35 mg (90% yield) of compound 10, mp 
269 – 272oC.  1H NMR (DMSO-d6) δ 10.60 (bs, 1 H, OH), 9.40 (bs, 1 H, OH), 9.30 (bs, 1 H, 
OH), 8.70 (s, 1 H, OH), 7.62 (d, J = 2.0 Hz, 1 H), 7.47 (dd, J = 9.0, 2.0 Hz, 1 H), 6.86 (d, J = 9.0 
Hz, 1 H), 6.42 (d, J = 2.0 Hz, 1 H), 6.31 (d, J = 2.0 Hz, 1 H), 3.98 (t, J = 7.0 Hz, 2 H), 1.77 
(sextet, J = 7.0 Hz, 2 H), 1.08 (t, J = 7.0 Hz, 3 H). 13C NMR δ 171.0, 162.4, 160.0, 157.9, 146.9, 
145.1, 141.7, 137.2, 122.3, 119.1, 115.6, 114.5, 105.2, 104.3, 96.4, 94.4, 69.8, 22.0, 10.5.  MS 
(electrospray) m/z 345.5 (M+H+; 100%), 303.1.  HRMS calcd for C18H17O7+ (M+H+) 345.0969, 
found 345.0972. 
 
Screening of compounds 1 – 10 and 29 for anti-influenza virus activity:7  Influenza virus Oh7 
was inoculated to two-day-old monolayer of Madin-Darby canine kidney (MDCK) cells in 6-
well plates at a multiplicity of infection (MOI) of 0.05 or 5.  The virus-infected cells were 
incubated in the presence of each compound at various concentrations from 0.1 to 150 μM with 
trypsin (10 μg/mL) for up to 4 days.  Amantadine or oseltamivir carboxylate was used as positive 
controls.  Virus replication was assessed with various methods including virus titration with 
TCID50 method, and real-time qRT-PCR.7 
